Effects of 2'-deoxycoformycin and erythro-9-(2-hydroxy-3-nornyl)adenine on plasma levels and urinary excretion of 9-beta-D-arabinofuranosyladenine in the mouse 1,2,3.
D000225:Adenine / Q000031:analogs & derivatives* / Q000494:pharmacology; D058892:Adenosine Deaminase Inhibitors; D000818:Animals; D001381:Azepines / Q000494:pharmacology*; D003853:Deoxyribonucleosides / Q000494:pharmacology*; D008297:Male; D051379:Mice; D008815:Mice, Inbred Strains; D009700:Nucleoside Deaminases / Q000037:antagonists & inhibitors*; D013997:Time Factors; D014740:Vidarabine / Q000097:blood / Q000378:metabolism* / Q000652:urine
D058892:Adenosine Deaminase Inhibitors; D001381:Azepines; D003853:Deoxyribonucleosides; D009700:Nucleoside Deaminases; D014740:Vidarabine; D000225:Adenine